Sign In
News Digest /
Income Statements
Income Statements
09:04am, Tuesday, May 06, 2025
Company Overview: Krystal Biotech, Inc. (NASDAQ: KRYS) is a biotechnology company focused on developing and commercializing genetic medicines. The company's lead product, VYJUVEK, has recently received FDA and EMA approvals for treating dystrophic epidermolysis bullosa (DEB).
Recent Financial Per...
09:04am, Tuesday, May 06, 2025
Global Business Travel Group, Inc. (NASDAQ: APSG) has recently released its financial results for the first quarter of 2025, highlighting both positive developments and challenges in its income statement.
Positive Aspects:
Total Revenue: Increased by 2% to $621 million compared to $610 million i...
09:04am, Tuesday, May 06, 2025
Company Overview:
Aligos Therapeutics, Inc. (NASDAQ: ALGS) is a clinical-stage biotechnology company focused on developing innovative therapeutics for viral diseases and liver diseases, including treatments for chronic hepatitis B virus (HBV) infection and metabolic dysfunction-associated steatoh...
09:03am, Tuesday, May 06, 2025
Company Overview: Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) continues to expand its footprint in the neuroscience sector, particularly in treating rare neurological diseases. The company focuses on innovative treatments, with its leading product, WAKIX, approved for sleep-related disorder...
09:03am, Tuesday, May 06, 2025
CCC Intelligent Solutions Holdings Inc. (NYSE: CCCS) - Q1 2025 Review
CCC Intelligent Solutions Holdings Inc. has posted its quarterly results showcasing a mixed performance. Here are the key highlights and statistics from their March 31, 2025, financial statements.
Positive Aspects:
Revenue Gro...
09:02am, Tuesday, May 06, 2025
Angel Oak Mortgage REIT, Inc. (NYSE: AOMR) has recently released its Q1 2025 financial results, showcasing a mix of promising developments and notable challenges.
Key Highlights from the Income Statement:
Net Interest Income: Increased by 17.6% year-over-year to $10.1 million.
Interest Income: R...
09:02am, Tuesday, May 06, 2025
CorMedix Inc. (NYSE: CRMD) has released its financials for the quarter ended March 31, 2025. The company is focused on commercializing its lead product, DefenCath, an FDA-approved antimicrobial catheter lock solution designed to reduce bloodstream infections in patients undergoing chronic hemodia...
09:01am, Tuesday, May 06, 2025
Douglas Elliman Inc. (NYSE: DOUG) has released its quarterly financial report for the period ended March 31, 2025. Here’s a summary of key financial insights:
Positive Aspects:
Revenue Growth: Total revenues increased to $253.4 million from $200.2 million year-over-year, highlighting a strong de...
09:01am, Tuesday, May 06, 2025
Vishay Precision Group, Inc. (NYSE: VPG) recently reported its financial results for the fiscal quarter ending March 29, 2025. The results illustrate a challenging quarter for the company amid changing market dynamics.
Key Financial Highlights:
Net Revenues: $71.7 million, down 11.2% from $80.8 ...
09:01am, Tuesday, May 06, 2025
Company Overview: Amalgamated Financial Corp. (NASDAQ: AMAL) focuses on socially responsible banking, primarily serving advocacy-based non-profits and socially conscious businesses. As of March 31, 2025, their total assets reached $8.29 billion, with $4.62 billion in net loans and $7.41 billion i...
09:00am, Tuesday, May 06, 2025
Company Overview: Ichor Holdings, Ltd. (NASDAQ: ICHR) is a leader in the design and manufacturing of critical fluid delivery systems for semiconductor capital equipment. Their products are essential for processes in semiconductor manufacturing, where precision is critical.
Recent Financial Perfor...
08:07am, Tuesday, May 06, 2025
Pediatrix Medical Group, Inc. (NYSE: MD) has released its quarterly results for the period ending March 31, 2025. The company, a leading provider of physician services including newborn and pediatric care, reported mixed results in its income statement and continued to navigate various operationa...
08:06am, Tuesday, May 06, 2025
Waters Corporation (NYSE: WAT) - Q1 2025 Financial Overview
Waters Corporation has released its financial results for the first quarter ended March 29, 2025. The company achieved a 4% year-over-year increase in total net sales, primarily due to rising customer demand for its liquid chromatography...
08:06am, Tuesday, May 06, 2025
Orthofix Medical Inc. (NASDAQ: OFIX)
As of the first quarter of 2025, Orthofix Medical Inc. has released its financial results, revealing a mixed performance. Below are key points from the income statement and other relevant corporate updates:
Net Sales: $193.6 million, up 2.7% from $188.6 milli...
08:06am, Tuesday, May 06, 2025
First Watch Restaurant Group, Inc. (NASDAQ: FWRG) reports its first quarter results for 2025, showing mixed performance and challenges in a competitive market. The company operates and franchises restaurants focused on breakfast, brunch, and lunch across 30 states in the U.S.
Key Highlights:
Tot...
08:05am, Tuesday, May 06, 2025
Company OverviewUpstream Bio, Inc. (NASDAQ: UPB) is a clinical-stage biopharmaceutical company focused on developing treatments for inflammatory diseases, primarily severe respiratory disorders. They are currently advancing their only product candidate, verekitug, which targets the Thymic Stromal...
08:05am, Tuesday, May 06, 2025
Fabrinet (NYSE: FN) - Q3 Financial Overview
Key Highlights:
Revenues: Increased by 19.2% to $871.8 million in Q3 2025 from $731.5 million in Q3 2024.
Net Income: Rose to $81.3 million (9.3% of revenues) compared to $80.9 million (11.1% of revenues) year-over-year.
Gross Profit: Improved to $102....
08:04am, Tuesday, May 06, 2025
QNB Corp. (OTCMKTS: QNBC) - Q1 2025 Financial Overview
Company Highlights:
Net Income: $2.578 million, or $0.69 per diluted share, down from $2.594 million, or $0.71 per diluted share in Q1 2024.
Net Interest Income: Increased by 13.46% to $11.537 million, driven by higher loan and securities in...
08:04am, Tuesday, May 06, 2025
Company Overview: Beam Therapeutics Inc. (NASDAQ: BEAM) is a biotechnology firm focused on developing precision genetic medicines. As of March 31, 2025, the company reported substantial advancements in its clinical programs but continues to incur significant losses.
Key Financial Highlights:
Lic...
08:03am, Tuesday, May 06, 2025
TScan Therapeutics, Inc. (NYSE: TCRX) continues to navigate a challenging landscape as a biotechnology company focused on developing innovative T cell receptor (TCR)-engineered therapies for cancer treatment. Recent developments reflect both promising advancements and significant financial hurdle...
08:03am, Tuesday, May 06, 2025
Dorman Products, Inc. (NASDAQ: DORM) has recently released its financials for the three months ended March 29, 2025. Here are the key insights from the company's income statement and overall performance:
Positive Aspects:
Net Sales Growth: Increased by $39.0 million (8.3%) year-over-year, rising...
08:03am, Tuesday, May 06, 2025
Neuronetics, Inc. (NASDAQ: STIM) - Quarterly Review (Ending March 31, 2025)
Neuronetics, Inc., a leader in neuroscience and manufacturer of the NeuroStar Advanced Therapy System, reported substantial growth in total revenues but continued to face operating losses. Here’s a concise overview of the...
08:02am, Tuesday, May 06, 2025
Bioventus Inc. (NASDAQ: BVS) has recently reported its financial performance for the quarter ended March 29, 2025, providing insight into its operational efficiency and market standing.
Key Highlights:
Net Sales: $123.9 million, a decrease of 4.3% compared to $129.5 million in Q1 2024.
Gross Pro...
08:02am, Tuesday, May 06, 2025
Company Overview
OnKure Therapeutics, Inc. (NASDAQ: OKUR) is a clinical-stage biopharmaceutical company focused on discovering and developing precision medicines targeting biologically validated drivers of cancers, especially those underserved by current therapies. They've pivoted significantly f...
08:02am, Tuesday, May 06, 2025
Parker-Hannifin Corporation (NYSE: PH) has released its quarterly report for the period ending March 31, 2025. Below is an overview of the significant aspects of the company's income statement along with some key statistics.
Positive Aspects:
Net Income: Increased to $961 million for Q1 2025 fro...
08:01am, Tuesday, May 06, 2025
Company Overview: Heron Therapeutics, Inc. (NASDAQ: HRTX) is a biotechnology company focused on developing and commercializing therapeutic innovations to enhance medical care, particularly in areas such as postoperative pain management and chemotherapy-induced nausea and vomiting.
Recent Developm...
08:01am, Tuesday, May 06, 2025
Shoals Technologies Group, Inc. (NASDAQ: SHLS) recently reported financial results for the three months ending March 31, 2025, revealing challenges amidst ongoing market expansions and operational adjustments.
Key Points from the Income Statement:
Revenue decreased by 11.5% year-over-year to $80...
08:01am, Tuesday, May 06, 2025
Premier, Inc. (NASDAQ: PINC) Overview
Premier, Inc. operates as a technology-driven healthcare improvement company in the United States, focusing on enhancing clinical, financial, and operational aspects of its members' healthcare services.
Recent Developments:
Divestitures: Premier divested its...
08:00am, Tuesday, May 06, 2025
Company Overview: Viridian Therapeutics, Inc. (NASDAQ: VRDN)
Viridian Therapeutics, Inc. is a biopharmaceutical company actively engaged in the development of innovative treatments for serious and rare diseases, particularly focusing on therapies for Thyroid Eye Disease (TED) and engineered FcRn ...
07:02am, Tuesday, May 06, 2025
Gartner, Inc. (NYSE: IT) has recently reported its financial results for the quarter ending March 31, 2025. The company provides insights and guidance primarily through three segments: Research, Conferences, and Consulting. Here are the key points from the latest income statement and overall perf...
07:02am, Tuesday, May 06, 2025
TTM Technologies, Inc. (NASDAQ: TTMI) reported its financial results for the quarter ending March 31, 2025. Here's a detailed overview of the company's performance along with key statistics from the income statement.
Financial Highlights:
Net Sales: Increased to $648.7 million from $570.1 millio...
07:01am, Tuesday, May 06, 2025
Matson, Inc. (NYSE: MATX) has recently reported its Q1 2025 results, revealing significant changes in its financial performance compared to Q1 2024.
Key Financial Highlights:
Total Operating Revenue: Increased to $782.0 million in Q1 2025, up by 8.3% from $722.1 million in Q1 2024.
Operating Inc...
07:01am, Tuesday, May 06, 2025
Ducommun Incorporated (NYSE: DCO) recently reported its financial results for the quarter ending March 29, 2025. The company, a key player in the aerospace and defense sectors, continues to demonstrate resilience despite facing challenges.
Positive Aspects:
Net Revenues: Reported at $194.1 milli...
07:01am, Tuesday, May 06, 2025
Company Overview: Vivid Seats Inc. (NASDAQ: SEAT) is an online ticket marketplace connecting fans with ticket sellers. The company has two primary segments: Marketplace and Resale, providing access to live concert, sports, and theater events.
Key Financial Highlights (Q1 2025):
Total Revenues: $...
07:00am, Tuesday, May 06, 2025
Company Overview
Jacobs Solutions Inc. (NYSE: J) is actively engaged in delivering a wide range of professional and technical services. The company has been undergoing significant transformations, highlighted by its recent operational strategies and financial maneuvers aimed at increasing its ma...
06:00pm, Monday, May 05, 2025
FTAI Aviation Ltd. (NASDAQ: FTAI) has released its financial results for the first quarter ended March 31, 2025, showcasing notable growth but also highlighting some concerning trends.
Key Points from the Q1 2025 Income Statement:
Total Revenues: Increased to $502.1 million from $326.7 million i...
05:05pm, Monday, May 05, 2025
BWX Technologies, Inc. (NYSE: BWXT) reported its first-quarter financial results for 2025, revealing both promising growth and areas of concern.
Key Highlights from Q1 2025 Income Statement:
Revenues increased by 13.0% to $682.3 million, up from $603.9 million in Q1 2024.
Operating income also r...
05:05pm, Monday, May 05, 2025
Company Overview
Immuneering Corporation (NASDAQ: IMRX) is a clinical-stage oncology company focused on developing therapies targeting RAS and RAF mutations through novel approaches in cancer treatment.
Recent Developments
- Launched a Phase 1/2a clinical trial for lead candidate IMM-1-104; inter...
05:04pm, Monday, May 05, 2025
Interparfums, Inc. (NASDAQ: IPAR) has released its earnings for the first quarter of 2025, showcasing both strengths and challenges in its income statement.
Key Highlights from the Income Statement:
Net Sales: Increased by 5%, reaching $338.8 million compared to $324.0 million in Q1 2024.
Gross ...
05:04pm, Monday, May 05, 2025
Wheels Up Experience Inc. (NYSE: UP) has reported its financial performance for Q1 2025, revealing a challenging landscape with both positive and negative elements on its income statement.
Positive Aspects:
Despite the decline, total revenue was $177.5 million, only a 10% decrease from $197.1 mi...
